Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-05 Sale | 2026-10-06 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Bowen Matthew Principal Accounting Officer | 13 | $10.56 | $137 | 25,891 (Direct) | View |
| 2026-07-16 Sale | 2026-07-17 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 9,500 | $23.18 | $220,219 | 585,038 (Direct) | View |
| 2026-07-15 Sale | 2026-07-16 4:10 pm | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 4,351 | $23.38 | $101,730 | 89,318 (Direct) | View |
| 2026-07-06 Sale | 2026-07-07 4:41 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $23.31 | $139,849 | 265,135 (Direct) | View |
| 2026-06-30 Sale | 2026-07-01 4:57 pm | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 5,407 | $24.5 | $132,472 | 141,705 (Direct) | View |
| 2026-06-29 Sale | 2026-06-30 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 6,000 | $22.95 | $137,700 | 119,992 (Direct) | View |
| 2026-06-29 Sale | 2026-06-30 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 10,000 | $23.11 | $231,100 | 2,100 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 41,845 | $21.08 | $882,203 | 221,992 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,175 | $20 | $43,500 | 93,669 (Direct) | View |
| 2026-06-23 Sale | 2026-06-25 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $20 | $60,000 | 271,135 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,176 | $19 | $41,344 | 95,844 (Direct) | View |
| 2026-06-17 Sale | 2026-06-18 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $19 | $57,000 | 274,135 (Direct) | View |
| 2026-06-01 Sale | 2026-06-02 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 5,466 | $19.44 | $106,253 | 594,538 (Direct) | View |
| 2026-05-29 Sale | 2026-06-01 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $19.87 | $119,220 | 277,135 (Direct) | View |
| 2026-05-27 Sale | 2026-05-28 7:10 pm | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,175 | $20 | $43,500 | 98,020 (Direct) | View |
| 2026-05-22 Sale | 2026-05-26 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,176 | $19 | $41,344 | 100,195 (Direct) | View |
| 2026-05-21 Sale | 2026-05-22 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 10,000 | $18.01 | $180,100 | 12,100 (Direct) | View |
| 2026-05-01 Sale | 2026-05-05 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 5,467 | $18.92 | $103,447 | 600,004 (Direct) | View |
| 2026-04-14 Sale | 2026-04-15 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 8,000 | $17.64 | $141,125 | 605,471 (Direct) | View |
| 2026-04-09 Sale | 2026-04-10 4:07 pm | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip Chief Business & Legal Officer | 5,845 | $17.69 | $103,413 | 55,000 (Direct) | View |
| 2026-03-04 Sale | 2026-03-05 5:24 pm | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 139 | $17.96 | $2,496 | 22,554 (Direct) | View |
| 2026-03-02 Sale | 2026-03-04 4:50 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 5,466 | $17.92 | $97,974 | 613,471 (Direct) | View |
| 2026-02-27 Sale | 2026-03-02 5:02 pm | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 25,700 | $18.09 | $464,886 | 23,229 (Direct) | View |
| 2026-02-23 Sale | 2026-02-24 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 9,189 | $19.5 | $179,161 | 65,837 (Direct) | View |
| 2026-01-07 Sale | 2026-01-09 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 5,466 | $23.49 | $128,373 | 618,937 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 4:06 pm | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip Chief Business & Legal Officer | 3,155 | $15.17 | $47,861 | 186,845 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 4:05 pm | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,629 | $15.17 | $39,882 | 220,371 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 4:04 pm | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 1,039 | $15.17 | $15,762 | 22,693 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 4:04 pm | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 10,135 | $15.17 | $153,748 | 1,030,403 (Direct) | View |
| 2026-01-05 Sale | 2026-01-05 4:04 pm | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 3,155 | $15.17 | $47,861 | 214,026 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-07-15 Exercise | 2026-07-16 4:10 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 4,351 | $3.98 | 89,318 (Direct) | View |
| 2026-07-15 Exercise | 2026-07-16 4:10 pm | N/A 2034-06-03 | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 4,351 | $0 | 89,318 (Direct) | View |
| 2026-07-06 Exercise | 2026-07-07 4:41 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $6.14 | 265,135 (Direct) | View |
| 2026-07-06 Exercise | 2026-07-07 4:41 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $0 | 265,135 (Direct) | View |
| 2026-07-01 Other | 2026-07-06 5:57 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director | 1,015,000 | $0 | 1,030,000 (Indirect) | View |
| 2026-06-30 Exercise | 2026-07-01 4:57 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 5,407 | $13.41 | 141,705 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-01 4:57 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 5,407 | $0 | 141,705 (Direct) | View |
| 2026-06-29 Exercise | 2026-06-30 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 6,000 | $7.56 | 119,992 (Direct) | View |
| 2026-06-29 Exercise | 2026-06-30 4:05 pm | N/A 2032-10-03 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 6,000 | $0 | 119,992 (Direct) | View |
| 2026-06-29 Exercise | 2026-06-30 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 10,000 | $4.16 | 2,100 (Direct) | View |
| 2026-06-29 Exercise | 2026-06-30 4:05 pm | N/A 2034-06-12 | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 10,000 | $0 | 2,100 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 36,000 | $7.56 | 221,992 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A 2032-10-03 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 36,000 | $0 | 221,992 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,175 | $3.98 | 93,669 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A 2034-06-03 | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,175 | $0 | 93,669 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $6.14 | 271,135 (Direct) | View |
| 2026-06-23 Exercise | 2026-06-25 4:05 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $0 | 271,135 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,176 | $3.98 | 95,844 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:05 pm | N/A 2034-06-03 | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,176 | $0 | 95,844 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $6.14 | 274,135 (Direct) | View |
| 2026-06-17 Exercise | 2026-06-18 4:05 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 3,000 | $0 | 274,135 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 6:44 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 4:05 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | SCHIFF ANDREW N Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 4:05 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 4:05 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 4:05 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | Blackwell Kimberly Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 4:05 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | Hughes Eric A Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-12 4:05 pm | N/A 2036-06-11 | Monte Rosa Therapeutics Inc. | GLUE | Siu Christine Director | 25,800 | $0 | 25,800 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $6.14 | 277,135 (Direct) | View |
| 2026-05-29 Exercise | 2026-06-01 4:05 pm | N/A 2031-04-12 | Monte Rosa Therapeutics Inc. | GLUE | Townson Sharon Chief Scientific Officer | 6,000 | $0 | 277,135 (Direct) | View |
| 2026-05-27 Exercise | 2026-05-28 7:10 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,175 | $3.98 | 98,020 (Direct) | View |
| 2026-05-27 Exercise | 2026-05-28 7:10 pm | N/A 2034-06-03 | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,175 | $0 | 98,020 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-26 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,176 | $3.98 | 100,195 (Direct) | View |
| 2026-05-22 Exercise | 2026-05-26 4:05 pm | N/A 2034-06-03 | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 2,176 | $0 | 100,195 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 10,000 | $4.16 | 12,100 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-22 4:05 pm | N/A 2034-06-12 | Monte Rosa Therapeutics Inc. | GLUE | Manning Anthony M. Director | 10,000 | $0 | 12,100 (Direct) | View |
| 2026-04-06 Option Award | 2026-04-07 4:10 pm | N/A 2036-04-05 | Monte Rosa Therapeutics Inc. | GLUE | Bowen Matthew Principal Accounting Officer | 23,800 | $0 | 45,404 (Direct) | View |
Ownership | 2026-04-07 4:05 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Bowen Matthew Principal Accounting Officer | 0 | $0 | 64,629 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 5:02 pm | N/A N/A | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 25,700 | $13.41 | 23,229 (Direct) | View |
| 2026-02-27 Exercise | 2026-03-02 5:02 pm | N/A 2032-02-29 | Monte Rosa Therapeutics Inc. | GLUE | Dunn Edmund Principal Accounting Officer | 25,700 | $0 | 23,229 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:06 pm | N/A 2036-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Nickson Philip Chief Business & Legal Officer | 154,000 | $0 | 186,845 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:05 pm | N/A 2036-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Champoux Jennifer Chief Operating Officer | 193,000 | $0 | 220,371 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:04 pm | N/A 2036-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Warmuth Markus President & CEO | 496,000 | $0 | 1,030,403 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:04 pm | N/A 2036-01-01 | Monte Rosa Therapeutics Inc. | GLUE | Janku Filip Chief Medical Officer | 170,000 | $0 | 214,026 (Direct) | View |